Analysen von Michael Leuchten
| 29.07.21 | AstraZeneca Buy | UBS AG | |
| 27.07.21 | Sartorius vz. Sell | UBS AG | |
| 22.07.21 | Roche Neutral | UBS AG | |
| 21.07.21 | Sartorius vz. Sell | UBS AG | |
| 21.07.21 | AstraZeneca Buy | UBS AG | |
| 19.07.21 | Roche Neutral | UBS AG | |
| 15.07.21 | AstraZeneca Buy | UBS AG | |
| 14.07.21 | AstraZeneca Buy | UBS AG | |
|
Werbung
|
|||
| 07.07.21 | Sartorius vz. Sell | UBS AG | |
| 01.07.21 | Fresenius Medical Care (FMC) St. Buy | UBS AG | |
| 28.06.21 | Novo Nordisk Neutral | UBS AG | |
| 24.06.21 | Bayer buy | UBS AG | |
| 17.06.21 | AstraZeneca buy | UBS AG | |
| 09.06.21 | Merck Neutral | UBS AG | |
| 07.06.21 | AstraZeneca buy | UBS AG | |
| 26.05.21 | Bayer buy | UBS AG | |
| 20.05.21 | AstraZeneca buy | UBS AG | |
| 20.05.21 | Bayer buy | UBS AG | |
| 19.05.21 | Bayer buy | UBS AG | |
| 18.05.21 | Merck Neutral | UBS AG | |
| 17.05.21 | Bayer buy | UBS AG | |
| 13.05.21 | Bayer buy | UBS AG | |
| 12.05.21 | Merck Neutral | UBS AG | |
| 07.05.21 | AstraZeneca buy | UBS AG | |
| 07.05.21 | Fresenius Medical Care (FMC) St. buy | UBS AG | |
| 07.05.21 | Fresenius Neutral | UBS AG | |
| 06.05.21 | Fresenius Neutral | UBS AG | |
| 06.05.21 | Fresenius Medical Care (FMC) St. buy | UBS AG | |
| 05.05.21 | Merck Neutral | UBS AG | |
| 30.04.21 | AstraZeneca buy | UBS AG | |
| 23.04.21 | Sartorius vz. Sell | UBS AG | |
| 19.04.21 | AstraZeneca buy | UBS AG | |
| 15.04.21 | GSK Neutral | UBS AG | |
| 14.04.21 | AstraZeneca buy | UBS AG | |
| 07.04.21 | AstraZeneca buy | UBS AG | |
| 26.03.21 | AstraZeneca buy | UBS AG | |
| 23.03.21 | AstraZeneca buy | UBS AG | |
| 23.03.21 | Roche Neutral | UBS AG | |
| 22.03.21 | Roche Neutral | UBS AG | |
| 15.03.21 | Roche Neutral | UBS AG | |
| 11.03.21 | Bayer buy | UBS AG | |
| 08.03.21 | Roche Neutral | UBS AG | |
| 04.03.21 | Merck Neutral | UBS AG | |
| 02.03.21 | AstraZeneca buy | UBS AG | |
| 26.02.21 | Bayer buy | UBS AG | |
| 25.02.21 | Bayer buy | UBS AG | |
| 25.02.21 | AstraZeneca buy | UBS AG | |
| 22.02.21 | Bayer buy | UBS AG | |
| 18.02.21 | Novo Nordisk Neutral | UBS AG | |
| 18.02.21 | AstraZeneca Neutral | UBS AG | |